Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA).
about
Probiotics for preventing urinary tract infections in adults and childrenSingle dose antibiotics for treating uncomplicated urinary tract infection in non-pregnant womenSingle dose antibiotics for treating uncomplicated urinary tract infection in non-pregnant womenQuinolones for uncomplicated acute cystitis in womenNitrofurantoin compares favorably to recommended agents as empirical treatment of uncomplicated urinary tract infections in a decision and cost analysisReview of the literature and individual patients' data meta-analysis on efficacy and tolerance of nitroxoline in the treatment of uncomplicated urinary tract infectionsUrinary tract infections in older women: a clinical reviewHigh-throughput identification of chemical inhibitors of E. coli Group 2 capsule biogenesis as anti-virulence agentsMaintaining fluoroquinolone class efficacy: review of influencing factors.International Spinal Cord Injury Urinary Tract Infection Basic Data Set.Integrating Escherichia coli antimicrobial susceptibility data from multiple surveillance programs.Uropathogen resistance: are laboratory-generated data reliable enough?Urinary tract infections and lupus erythematosusOptimizing the diagnostic work-up of acute uncomplicated urinary tract infections.Susceptibility of urinary tract bacteria to fosfomycinTreatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days)Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis.In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin.Emergence of and risk factors for ciprofloxacin-gentamicin-resistant Escherichia coli urinary tract infections in a region of Quebec.Selective target inactivation rather than global metabolic dormancy causes antibiotic tolerance in uropathogens.Organic anion transporter 3 (oat3/slc22a8) interacts with carboxyfluoroquinolones, and deletion increases systemic exposure to ciprofloxacinManagement of uncomplicated urinary tract infectionsEscherichia coli global gene expression in urine from women with urinary tract infection.Discordance between patient report and chart review of risk factors for antimicrobial resistance in ED patients[National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients].Managing urinary tract infections in men.Characterization of a novel murine model of Staphylococcus saprophyticus urinary tract infection reveals roles for Ssp and SdrI in virulence.Antimicrobial susceptibility of bacteria isolated from urine samples obtained from nursing home residents.Predictive value of antimicrobial susceptibility from previous urinary tract infection in the treatment of re-infection.Epidemiology and unique aspects of aging and infectious diseases.Uncomplicated urinary tract infectionsMultidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000.Prevalence and risk factors for extended spectrum Beta-lactamase-producing uropathogens in patients with urinary tract infection.Cranberry juice fails to prevent recurrent urinary tract infection: results from a randomized placebo-controlled trial.The appropriateness of prescribing antibiotics in the community in Europe: study design.Efficacy and safety of a novel once-daily extended-release ciprofloxacin tablet formulation for treatment of uncomplicated urinary tract infection in women.The clinical and imaging presentation of acute "non complicated" pyelonephritis: a new profile for an ancient disease.Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United StatesErtapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study.Urinary tract infections: disease panorama and challenges.
P2860
Q24235033-D0DE0080-DF63-4E33-AF59-1957B7C8DA9EQ24235080-02E6822E-209D-4E88-A153-98DBE9AE4165Q24241173-DC9DED2B-5DCA-463C-BC6F-27B432CBD2BDQ24244971-241DFDA5-F154-402B-9E92-3C9C48EE8033Q24629644-BD024FD1-7B84-433C-87D9-1E09AE64913BQ26996226-6B6779F1-4C55-4809-A847-B2C862F29DB2Q27002570-C9B24A09-E2BA-43CB-A513-27292816ECACQ28474866-193E4770-0C86-422C-9702-03D6185FC112Q30310427-B80A43C0-E2C1-46B5-BC0D-F7ACA43B921CQ30658014-72D04DE0-D3FE-443A-BF31-40BE171B3795Q30992335-279CE821-6208-4F5D-B37F-752701D103AEQ31101643-559B1A9C-DC7A-473F-9F45-EDB2D3A7E06AQ33359987-09EE415D-7354-4A1B-848C-33735F5AE233Q33390771-63AEDE58-E1A0-46D7-BB1B-3B3C55B9A4C1Q33494283-CAA34C6B-F4B2-4B72-A917-42E8FEF572BAQ33494958-542D228C-411E-441A-9204-D9AD7C4DB7D5Q33555328-4BD51D07-DB64-4571-8CE0-7A37E9620BC1Q33558996-FFEC2E10-13C5-4EFF-A1E1-5B85C1FB0073Q33593668-7E503859-1FC2-4779-A1F6-0BCE76043C9BQ33622796-0750690C-0533-484D-8430-968B437D1124Q33658156-EB2E317F-CC78-46ED-BF60-55E7D1F216D6Q33729556-11E08974-9517-4682-ABD7-050CE7967CEEQ33750030-AAB07FE1-7E58-46AD-B197-99CE1D6F6858Q33784893-491D27F8-2E21-4E40-BD55-ACC2C650FBA6Q33818308-B8784FFA-930D-4605-84D9-67110935A999Q33823453-3E67321F-0092-48C8-A99A-822537740982Q33826150-E8DB13D1-2B32-438A-8C4C-2948D8D287FDQ33835311-D36337B8-7850-472E-8902-64F7069E61DFQ33950011-B1C19B48-3498-4EB9-885D-6E5F09A08570Q33958214-A28BD185-76A0-43BE-A23A-6EEABE809C7FQ33966916-FA3202C4-F3C9-4494-B137-75FE7314D853Q33982041-ED3F8BDE-0B71-4934-9416-B06977A7FA8AQ34009487-4C039498-0334-474A-94D8-F2980B8B859AQ34024971-02AF7EF3-B905-458F-ADC8-4C6C23A1C1D8Q34059751-CCFA55A8-56EB-4D3A-8A38-9D329C6BD322Q34077082-3483345A-0250-4621-9A87-A3173F230B32Q34101984-6007BF65-47CD-4C38-8A9F-29EDB321C340Q34110686-B65AE9F7-9385-4A58-BFCE-963602C0D6C8Q34112476-30E2D4B8-5528-47B7-81D6-FE6ECA38F232Q34136716-42AAE5D2-D3BF-4A73-B195-AEFE7B8ED536
P2860
Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA).
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Guidelines for antimicrobial t ...... ses Society of America (IDSA).
@ast
Guidelines for antimicrobial t ...... ses Society of America (IDSA).
@en
type
label
Guidelines for antimicrobial t ...... ses Society of America (IDSA).
@ast
Guidelines for antimicrobial t ...... ses Society of America (IDSA).
@en
prefLabel
Guidelines for antimicrobial t ...... ses Society of America (IDSA).
@ast
Guidelines for antimicrobial t ...... ses Society of America (IDSA).
@en
P2093
P356
P1476
Guidelines for antimicrobial t ...... ses Society of America (IDSA).
@en
P2093
P304
P356
10.1086/520427
P407
P577
1999-10-01T00:00:00Z